Cellectis S.A.

Biotechnology company · Paris, Lle-de-France, Île-de-France, France · Nasdaq: CLLS

Cellectis S.A. is a biotechnology company headquartered in Paris, Lle-de-France, Île-de-France, France. Its shares trade on Nasdaq under the ticker CLLS.

Profile compiled from public records. Is this your company? Request a correction or update

Cellectis at a glance

Typebiotechnology company

HeadquartersParis, Lle-de-France, Île-de-France, France

Stock listingNasdaq: CLLS

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1627281

Frequently asked questions about Cellectis

Where is Cellectis headquartered?

Cellectis S.A. is headquartered in Paris, Lle-de-France, Île-de-France, France.

What does Cellectis do?

Cellectis S.A. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Cellectis a public company?

Yes. Cellectis S.A. trades on Nasdaq under the ticker CLLS.

Similar companies

Gensight Biologics S.A.Paris, Île-de-France, France
Eyevensys S.A.S.Paris, Île-de-France, France
AB Science S.A.Paris, Île-de-France, France
DBV Technologies S.A.Châtillon, Île-de-France, France
Innate Pharma SAMarseille, Provence-Alpes-Côte d'Azur, France
PHAXIAM Therapeutics S.A.Lyon, Auvergne-Rhône-Alpes, France
Genfit S.A.Loos, Hauts-de-France, France
Cerenis Therapeutics Holding S.A.Labège, Occitanie, France

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences